Inhibition of antithrombin and bovine serum albumin native state aggregation by heparin

Protein native state aggregation, a major problem in pharmaceutical and biological processes, has been addressed pharmacologically by the addition of protein-binding excipients. Heparin (Hp), a highly sulfated polysaccharide, interacts with numerous proteins with moderate to high affinity, but repor...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1999. - 30(2014), 1 vom: 14. Jan., Seite 278-87
1. Verfasser: Minsky, Burcu Baykal (VerfasserIn)
Weitere Verfasser: Zheng, Bingqian, Dubin, Paul L
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antithrombins Recombinant Proteins Serum Albumin, Bovine 27432CM55Q Heparin 9005-49-6
LEADER 01000naa a22002652 4500
001 NLM233424865
003 DE-627
005 20231224095102.0
007 cr uuu---uuuuu
008 231224s2014 xx |||||o 00| ||eng c
024 7 |a 10.1021/la4039232  |2 doi 
028 5 2 |a pubmed24n0778.xml 
035 |a (DE-627)NLM233424865 
035 |a (NLM)24313340 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Minsky, Burcu Baykal  |e verfasserin  |4 aut 
245 1 0 |a Inhibition of antithrombin and bovine serum albumin native state aggregation by heparin 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 22.08.2014 
500 |a Date Revised 16.11.2017 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Protein native state aggregation, a major problem in pharmaceutical and biological processes, has been addressed pharmacologically by the addition of protein-binding excipients. Heparin (Hp), a highly sulfated polysaccharide, interacts with numerous proteins with moderate to high affinity, but reports about its effect on protein aggregation are contradictory. We studied the pH dependence of the aggregation of antithrombin (AT) and bovine serum albumin (BSA) in the presence and absence of heparin. High-precision turbidimetry showed strong aggregation for both AT and BSA in I = 10 mM NaCl, conditions at which electrostatically driven Hp binding and aggregation both occur, with more obvious aggregation of heparin-free AT appearing as larger aggregate size. Aggregation of AT was dramatically inhibited at Hp: protein 6:1 (mole ratio); however, the effect at 0.5:1 Hp:protein was greater for BSA. Frontal analysis capillary electrophoresis showed a much larger equilibrium association constant Kobs between Hp and AT, in accord with the onset of Hp binding at a higher pH; both effects are explained by the higher charge density of the positive domain for AT as revealed by modeling with DelPhi. The corresponding modeling images showed that these domains persist at high salt only for AT, consistent with the 160-fold drop in Kobs at 100 mM salt for BSA-Hp binding. The smaller inhibition effect for AT arises from the tendency of its uncomplexed monomer to form larger aggregates more rapidly, but the stronger binding of Hp to AT does not facilitate Hp-induced aggregate dissolution which occurs more readily for BSA. This can be attributed to the higher density of AT aggregates evidenced by higher fractal dimensions. Differences between inhibition and reversal by Hp arise because the former may depend on the stage at which Hp enters the aggregation process and the latter on aggregate size and morphology 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Antithrombins  |2 NLM 
650 7 |a Recombinant Proteins  |2 NLM 
650 7 |a Serum Albumin, Bovine  |2 NLM 
650 7 |a 27432CM55Q  |2 NLM 
650 7 |a Heparin  |2 NLM 
650 7 |a 9005-49-6  |2 NLM 
700 1 |a Zheng, Bingqian  |e verfasserin  |4 aut 
700 1 |a Dubin, Paul L  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1999  |g 30(2014), 1 vom: 14. Jan., Seite 278-87  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:30  |g year:2014  |g number:1  |g day:14  |g month:01  |g pages:278-87 
856 4 0 |u http://dx.doi.org/10.1021/la4039232  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 30  |j 2014  |e 1  |b 14  |c 01  |h 278-87